No Detail Found!

Cisplatin-induced Apoptosis is Promoted Via Cisplatin-induced Autophagy in Bladder Cancer Cells.

Author(s)
Zhiqiang Fan Department of Urology, Henan Provincial People's Hospital, Zhengzhou City, 450003, China
Xuejun Huangfu Department of Urology, Henan Provincial People's Hospital, Zhengzhou City, 450003, China
Zhonghua Liu Department of Urology, Henan Provincial People's Hospital, Zhengzhou City, 450003, China
Abstract
Objective: To investigate the eefcts of autophagy in cisplatin-induced apoptosis of bladder cancer cells. Methods: Bladder cancer cell T24 was regarded as cell model. The transmission electron microscope was used to detect autophagic vacuoles and the uflorescence microscope to detect the uflorescence accumulation profile of vectors for green uflorescent protein and microtubule associated protein 1 light chain 3 fusion protein (GFP-LC3). Protein immunoblotting was applied to detect the accumulation of LC3-II, thus detecting whether cisplatin could induce the bladder cancer T24 cell autophagy. Moreover, protein immunoblotting was also used to detect the autophagic relative signal pathway mammal target of rapamycin (mTOR) and the variation of ribosomal protein S6 kinase (P70S6K) with relative molecular mass 70 000 in downstream as well as the cleavage of apoptosis marker protein poly ADP-ribose polymerase (PARP). Aeftrwards, with the utilization of 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)2-(4-sulfophenyl)-2H-tetrazolium, inner salt (MTS), the viability changes in cisplatin-induced bladder cancer cells under the condition of autophagy promoting the presentation or absence of rapamycin were observed. Moreover, RNA interference was also adopted in this experiment to knockdown the LC3 expression. Results: Compared with the control group, the electron microscope revealed that cisplatin was able to induce plenty of autophagic vacuoles in bladder cancer cells. CFP-LC3 aggregation was viewed by the uflorescence microscope, showing a significant higher in cisplatin group than control group. The results of LC3 detected by protein immunoblotting indicated that the LC3-II content in cisplatin group was significantly enhanced with the prolongation of time and increase of cisplatin concentration. Especially, at the concentration of 50 and 100 µmol/L for 48 h with cisplatin treatment, the gray value of LC3-II/Actin (%) increased 30 and 44, respectively. Cisplatin treatment inhibited the phosphorylation of mTOR/P70S6K, and its phosphorylated strips were almost completely inhibited in the 100µmol/L for 48 h with cisplatin treatment. MTS results showed that cisplatin was able to lead to the loss of cell viability, which was 12% and 35% at the concentration of 50, and 100µmol/L for 24 h with cisplatin treatment. Moreover, the cell viability loss in autophagyinduced rapamycin and cisplatin combined treatment group was larger than that with singleuse cisplatin treatment in control group (F = 74.890, P < 0.01). Besides, RNA interference experiment revealed that knocking down autophagic relative gene LC3 could reduce the PARP cleavage induced by cisplatin and the apoptosis was decreased. Conclusion: Cisplatin could induce autophagy in bladder cancer cell T24, which promoted cisplatin-induced apoptosis.
Publication Details
Page(s) 69-77
DOI DOI not available
Published Journal: RADS Journal of Pharmacy & Pharmaceutical Sciences, Volume: 4, Issue: 1, Year: 2016

Request the full text from PASTIC

Keywords
Apoptosis, Cisplatin, Bladder cancer, Autophagy
References
ChenWQ,ZhengRS,ZhangSW, 2012.An analysis of cancer incidence in China,,China Cancer 21 161 -170
von der MaaseH,SengelovL, ., -
YaoX,WangHQ, 2004.New progress of clinical researches on the systematical chemotherapy of bladder cancer [J],Chin J Urol 25 860 -863
GalluzziL,VitaleI,AbramsJM, 2011.Molecular definitions of cell death subroutines: recommendations of the Nomenclature Committee on Cell Death 2012 [J],Cell Death Diefr 19 107 -120
KlionskyDJ,EmrSD, 2000.Autophagy as a regulated pathway of cellular degradation [J],Science 290 1717 -1721
LevineB,KroemerG., 2008.Autophagy in the pathogenesis of disease [J],Cell 132 27 -42
DegenhardtK,MathewR,BeaudoinB, 2006.Autophagy promotes tumor cell survival and restricts necrosis, inflammation and tumorigenesis,Cancer Cell 10 51 -64
GozuacikD,KimchiA, 2004.Autophagy as a cell death and tumor suppressor mechanism,Oncogene 23 2891 -2906
QuX,YuJ,BhagatG, 2003.Promotion of tumorigenesis by heterozygous disruption of the beclin 1 autophagy gene,J Clin Invest 112 1809 -1820
AmaravadiRK,YuD,LumJJ, 2007.Autophagy inhibition enhances therapyinduced apoptosis in a Myc-induced model of lymphoma [J],J Clin Invest 117 326 -336
XuY,YuH,QinH, .Inhibition of autophagy enhances cisplatin cytotoxicity through endoplasmic reticulum stress in human cervical cancer cells [J],Cancer -
MizushimaN., 2004.Methods for monitoring autophagy,Int J Biochem Cell Biol 36 2491 -2502
KlionskyDJ,AbdallaFC,AbeliovichH, 2012.Guidelines for the use and interpretation of assays for monitoring autophagy,Autophagy 8 445 -544
LiangC., 2010.Negative regulation of autophagy [J],Cell Death Diefr 17 1807 -1815
OliverFJ,de la RubiaG,RolliV, 1998.Importance of poly (ADP-ribose) polymerase and its cleavage in apoptosis. Lesson from an uncleavable mutant,J Biol Chem 273 33533 -33539
HeitmanJ,MovvaNR,HallMN, 1991.Targets for cell cycle arrest by the immunosuppressant rapamycin in yeast,Science 253 905 -909
WangD,LippardSJ, 2005.Cellular processing of platinum anticancer drugs [J],Nat Rev Drug Discov 4 307 -320
GonzalezVM,FuertesMA,AlonsoC, 2001.Is cisplatin-induced cell death always produced by apoptosis,Mol Pharmacol 59 657 -663
ScarlattiF,GranataR,MeijerAJ, 2009.Does autophagy have a license to kill mammalian cells [J],Cell Death Diefr 16 12 -20
TakahashiA,KimuraT,TakabatakeY, 2012.Autophagy guards against cisplatin-induced acute kidney injury [J],Am J Pathol 180 517 -525
RenJH,HeWS,NongL, 2010.Acquired cisplatin resistance in human lung adenocarcinoma cells is associated with enhanced autophagy [J],Cancer Biother Radiopharm 25 75 -80
LiuD,YangY,LiuQ, 2011.Inhibition of autophagy by 3-MA potentiates cisplatininduced apoptosis in esophageal squamous cell carcinoma cells [J],Med Oncol 28 105 -111
KangR,WangZH,WangBQ, 2012.Inhibition of autophagy-potentiated chemosensitivity to cisplatin in laryngeal cancer Hep-2 cells [J],Am J Otolaryngol 33 678 -684
XuN,ZhangJ,ShenC, 2012.Cisplatininduced downregulation of miR-199a-5p increases drug resistance by activating autophagy in HCC cell,Biochem Biophys Res Commun 423 826 -831
Harhaji-TrajkovicL,VilimanovichU,Kravic-StevovicT, 2009.AMPK-mediated autophagy inhibits apoptosis in cisplatintreated tumour cells [J],J Cell Mol Med 13 3644 -3654
NotteA,LeclereL,MichielsC, 2011.Autophagy as a mediator of chemotherapy-induced cell death in cancer,Biochem Pharmacol 82 427 -434
Eisenberg-LernerA,BialikS,SimonHU, 2009.Life and death partners: apoptosis, autophagy and the cross-talk between them [J],Cell Death Diefr 16 966 -975
HouW,HanJ,LuC, 2010.Autophagic degradation of active caspase-8: a crosstalk mechanism between autophagy and apoptosis,Autophagy 6 891 -900
JankuF,McconkeyDJ,HongDS, 2011.Autophagy as a target for anticancer therapy,Nat Rev Clin Oncol 8 528 -539
ChenS,RehmanSK,ZhangW, 1806.Autophagy is a therapeutic target in anticancer drug resistance [J],Biochim Biophys Acta 220 -229
0

Citations

0

Downloads

26

Views